Mayukh Sukhatme - 03 Dec 2024 Form 4 Insider Report for Roivant Sciences Ltd. (ROIV)

Role
Pres&Chief Investment Officer, Director
Signature
By: /s/ Jo Chen, as Attorney-in-Fact for Mayukh Sukhatme
Issuer symbol
ROIV
Transactions as of
03 Dec 2024
Net transactions value
-$44,572,477
Form type
4
Filing time
05 Dec 2024, 21:00:11 UTC
Previous filing
30 Jul 2024
Next filing
20 Dec 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ROIV Common Shares Other $44,572,477 -3,651,985 -16% $12.20 18,836,547 03 Dec 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents a transfer of Common Shares for estate planning purposes to a newly formed limited liability company with respect to which the reporting person does not have any voting or investment control.